GNTA
Genenta Science SpA ADRNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$16.23M
P/E Ratio
—
EPS
$-0.38
Beta
0.56
52W High
$6.20
52W Low
$0.59
50-Day MA
$0.89
200-Day MA
$2.33
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Genenta Science SpA ADR
Genenta Science SpA, a clinical-stage biotechnology company, is dedicated to the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company is headquartered in Milan, Italy.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-6.58M |
| Operating Margin | 0.00% |
| Return on Equity | -38.00% |
| Return on Assets | -17.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.08 |
| Price-to-Book | 0.65 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -11.48 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $23.43M |
| Float | $16.51M |
| % Insiders | 30.38% |
| % Institutions | 13.61% |
Data last updated: 4/8/2026